KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Net Equity Issued and Repurchased (2016 - 2025)

Historic Net Equity Issued and Repurchased for Novartis Ag (NVS) over the last 17 years, with Q3 2025 value amounting to $8.8 billion.

  • Novartis Ag's Net Equity Issued and Repurchased rose 1102.18% to $8.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 billion, marking a year-over-year increase of 1102.18%. This contributed to the annual value of $7.4 billion for FY2024, which is 444.63% up from last year.
  • According to the latest figures from Q3 2025, Novartis Ag's Net Equity Issued and Repurchased is $8.8 billion, which was up 1102.18% from $9.1 billion recorded in Q2 2025.
  • In the past 5 years, Novartis Ag's Net Equity Issued and Repurchased registered a high of $9.2 billion during Q2 2023, and its lowest value of $6.8 billion during Q3 2023.
  • Over the past 5 years, Novartis Ag's median Net Equity Issued and Repurchased value was $8.4 billion (recorded in 2021), while the average stood at $8.2 billion.
  • Its Net Equity Issued and Repurchased has fluctuated over the past 5 years, first plummeted by 1903.35% in 2023, then surged by 1682.06% in 2024.
  • Quarter analysis of 5 years shows Novartis Ag's Net Equity Issued and Repurchased stood at $8.0 billion in 2021, then grew by 0.76% to $8.1 billion in 2022, then decreased by 11.89% to $7.1 billion in 2023, then increased by 4.45% to $7.4 billion in 2024, then rose by 19.14% to $8.8 billion in 2025.
  • Its Net Equity Issued and Repurchased stands at $8.8 billion for Q3 2025, versus $9.1 billion for Q2 2025 and $8.6 billion for Q1 2025.